COVID-19 Impact on Global Memory Enhancement Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: CC836CB93BC6EN
QYResearch

Abstracts

This report focuses on the global Memory Enhancement Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Memory Enhancement Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Novartis
• Shire Pharmaceuticals
• Allergan Plc
• Cephalon
• AlternaScript
• Takeda Pharmaceutical Company
• Eisai
• Barr Pharmaceuticals

Market segment by Type, the product can be split into

• Aricept
• Razadyne
• Namenda
• Exelon
• Provigil
• Ritalin
• Adderall
• Others

Market segment by Application, split into

• Disease Treatment
• Academic Performance
• Athletic Performance
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Memory Enhancement Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Memory Enhancement Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Memory Enhancement Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Memory Enhancement Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Memory Enhancement Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Aricept
  1.4.3 Razadyne
  1.4.4 Namenda
  1.4.5 Exelon
  1.4.6 Provigil
  1.4.7 Ritalin
  1.4.8 Adderall
  1.4.9 Others
1.5 Market by Application
  1.5.1 Global Memory Enhancement Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Disease Treatment
  1.5.3 Academic Performance
  1.5.4 Athletic Performance
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Memory Enhancement Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Memory Enhancement Drugs Industry
    1.6.1.1 Memory Enhancement Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Memory Enhancement Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Memory Enhancement Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Memory Enhancement Drugs Market Perspective (2015-2026)
2.2 Memory Enhancement Drugs Growth Trends by Regions
  2.2.1 Memory Enhancement Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Memory Enhancement Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Memory Enhancement Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Memory Enhancement Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Memory Enhancement Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Memory Enhancement Drugs Players by Market Size
  3.1.1 Global Top Memory Enhancement Drugs Players by Revenue (2015-2020)
  3.1.2 Global Memory Enhancement Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Memory Enhancement Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Memory Enhancement Drugs Market Concentration Ratio
  3.2.1 Global Memory Enhancement Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Memory Enhancement Drugs Revenue in 2019
3.3 Memory Enhancement Drugs Key Players Head office and Area Served
3.4 Key Players Memory Enhancement Drugs Product Solution and Service
3.5 Date of Enter into Memory Enhancement Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Memory Enhancement Drugs Historic Market Size by Type (2015-2020)
4.2 Global Memory Enhancement Drugs Forecasted Market Size by Type (2021-2026)

5 MEMORY ENHANCEMENT DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Memory Enhancement Drugs Market Size by Application (2015-2020)
5.2 Global Memory Enhancement Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Memory Enhancement Drugs Market Size (2015-2020)
6.2 Memory Enhancement Drugs Key Players in North America (2019-2020)
6.3 North America Memory Enhancement Drugs Market Size by Type (2015-2020)
6.4 North America Memory Enhancement Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Memory Enhancement Drugs Market Size (2015-2020)
7.2 Memory Enhancement Drugs Key Players in Europe (2019-2020)
7.3 Europe Memory Enhancement Drugs Market Size by Type (2015-2020)
7.4 Europe Memory Enhancement Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Memory Enhancement Drugs Market Size (2015-2020)
8.2 Memory Enhancement Drugs Key Players in China (2019-2020)
8.3 China Memory Enhancement Drugs Market Size by Type (2015-2020)
8.4 China Memory Enhancement Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Memory Enhancement Drugs Market Size (2015-2020)
9.2 Memory Enhancement Drugs Key Players in Japan (2019-2020)
9.3 Japan Memory Enhancement Drugs Market Size by Type (2015-2020)
9.4 Japan Memory Enhancement Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Memory Enhancement Drugs Market Size (2015-2020)
10.2 Memory Enhancement Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Memory Enhancement Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Memory Enhancement Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Memory Enhancement Drugs Market Size (2015-2020)
11.2 Memory Enhancement Drugs Key Players in India (2019-2020)
11.3 India Memory Enhancement Drugs Market Size by Type (2015-2020)
11.4 India Memory Enhancement Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Memory Enhancement Drugs Market Size (2015-2020)
12.2 Memory Enhancement Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Memory Enhancement Drugs Market Size by Type (2015-2020)
12.4 Central & South America Memory Enhancement Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Memory Enhancement Drugs Introduction
  13.1.4 Pfizer Revenue in Memory Enhancement Drugs Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Memory Enhancement Drugs Introduction
  13.2.4 Novartis Revenue in Memory Enhancement Drugs Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Shire Pharmaceuticals
  13.3.1 Shire Pharmaceuticals Company Details
  13.3.2 Shire Pharmaceuticals Business Overview and Its Total Revenue
  13.3.3 Shire Pharmaceuticals Memory Enhancement Drugs Introduction
  13.3.4 Shire Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2015-2020)
  13.3.5 Shire Pharmaceuticals Recent Development
13.4 Allergan Plc
  13.4.1 Allergan Plc Company Details
  13.4.2 Allergan Plc Business Overview and Its Total Revenue
  13.4.3 Allergan Plc Memory Enhancement Drugs Introduction
  13.4.4 Allergan Plc Revenue in Memory Enhancement Drugs Business (2015-2020)
  13.4.5 Allergan Plc Recent Development
13.5 Cephalon
  13.5.1 Cephalon Company Details
  13.5.2 Cephalon Business Overview and Its Total Revenue
  13.5.3 Cephalon Memory Enhancement Drugs Introduction
  13.5.4 Cephalon Revenue in Memory Enhancement Drugs Business (2015-2020)
  13.5.5 Cephalon Recent Development
13.6 AlternaScript
  13.6.1 AlternaScript Company Details
  13.6.2 AlternaScript Business Overview and Its Total Revenue
  13.6.3 AlternaScript Memory Enhancement Drugs Introduction
  13.6.4 AlternaScript Revenue in Memory Enhancement Drugs Business (2015-2020)
  13.6.5 AlternaScript Recent Development
13.7 Takeda Pharmaceutical Company
  13.7.1 Takeda Pharmaceutical Company Company Details
  13.7.2 Takeda Pharmaceutical Company Business Overview and Its Total Revenue
  13.7.3 Takeda Pharmaceutical Company Memory Enhancement Drugs Introduction
  13.7.4 Takeda Pharmaceutical Company Revenue in Memory Enhancement Drugs Business (2015-2020)
  13.7.5 Takeda Pharmaceutical Company Recent Development
13.8 Eisai
  13.8.1 Eisai Company Details
  13.8.2 Eisai Business Overview and Its Total Revenue
  13.8.3 Eisai Memory Enhancement Drugs Introduction
  13.8.4 Eisai Revenue in Memory Enhancement Drugs Business (2015-2020)
  13.8.5 Eisai Recent Development
13.9 Barr Pharmaceuticals
  13.9.1 Barr Pharmaceuticals Company Details
  13.9.2 Barr Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 Barr Pharmaceuticals Memory Enhancement Drugs Introduction
  13.9.4 Barr Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2015-2020)
  13.9.5 Barr Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Memory Enhancement Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Memory Enhancement Drugs Revenue
Table 3. Ranking of Global Top Memory Enhancement Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Memory Enhancement Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Aricept
Table 6. Key Players of Razadyne
Table 7. Key Players of Namenda
Table 8. Key Players of Exelon
Table 9. Key Players of Provigil
Table 10. Key Players of Ritalin
Table 11. Key Players of Adderall
Table 12. Key Players of Others
Table 13. COVID-19 Impact Global Market: (Four Memory Enhancement Drugs Market Size Forecast Scenarios)
Table 14. Opportunities and Trends for Memory Enhancement Drugs Players in the COVID-19 Landscape
Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 16. Key Regions/Countries Measures against Covid-19 Impact
Table 17. Proposal for Memory Enhancement Drugs Players to Combat Covid-19 Impact
Table 18. Global Memory Enhancement Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 19. Global Memory Enhancement Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 20. Global Memory Enhancement Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 21. Global Memory Enhancement Drugs Market Share by Regions (2015-2020)
Table 22. Global Memory Enhancement Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 23. Global Memory Enhancement Drugs Market Share by Regions (2021-2026)
Table 24. Market Top Trends
Table 25. Key Drivers: Impact Analysis
Table 26. Key Challenges
Table 27. Memory Enhancement Drugs Market Growth Strategy
Table 28. Main Points Interviewed from Key Memory Enhancement Drugs Players
Table 29. Global Memory Enhancement Drugs Revenue by Players (2015-2020) (Million US$)
Table 30. Global Memory Enhancement Drugs Market Share by Players (2015-2020)
Table 31. Global Top Memory Enhancement Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Memory Enhancement Drugs as of 2019)
Table 32. Global Memory Enhancement Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 33. Key Players Headquarters and Area Served
Table 34. Key Players Memory Enhancement Drugs Product Solution and Service
Table 35. Date of Enter into Memory Enhancement Drugs Market
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. Global Memory Enhancement Drugs Market Size Share by Type (2015-2020)
Table 39. Global Memory Enhancement Drugs Revenue Market Share by Type (2021-2026)
Table 40. Global Memory Enhancement Drugs Market Size Share by Application (2015-2020)
Table 41. Global Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. Global Memory Enhancement Drugs Market Size Share by Application (2021-2026)
Table 43. North America Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$)
Table 44. North America Key Players Memory Enhancement Drugs Market Share (2019-2020)
Table 45. North America Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. North America Memory Enhancement Drugs Market Share by Type (2015-2020)
Table 47. North America Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. North America Memory Enhancement Drugs Market Share by Application (2015-2020)
Table 49. Europe Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$)
Table 50. Europe Key Players Memory Enhancement Drugs Market Share (2019-2020)
Table 51. Europe Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. Europe Memory Enhancement Drugs Market Share by Type (2015-2020)
Table 53. Europe Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. Europe Memory Enhancement Drugs Market Share by Application (2015-2020)
Table 55. China Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$)
Table 56. China Key Players Memory Enhancement Drugs Market Share (2019-2020)
Table 57. China Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. China Memory Enhancement Drugs Market Share by Type (2015-2020)
Table 59. China Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. China Memory Enhancement Drugs Market Share by Application (2015-2020)
Table 61. Japan Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$)
Table 62. Japan Key Players Memory Enhancement Drugs Market Share (2019-2020)
Table 63. Japan Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Japan Memory Enhancement Drugs Market Share by Type (2015-2020)
Table 65. Japan Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Japan Memory Enhancement Drugs Market Share by Application (2015-2020)
Table 67. Southeast Asia Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$)
Table 68. Southeast Asia Key Players Memory Enhancement Drugs Market Share (2019-2020)
Table 69. Southeast Asia Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. Southeast Asia Memory Enhancement Drugs Market Share by Type (2015-2020)
Table 71. Southeast Asia Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. Southeast Asia Memory Enhancement Drugs Market Share by Application (2015-2020)
Table 73. India Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$)
Table 74. India Key Players Memory Enhancement Drugs Market Share (2019-2020)
Table 75. India Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. India Memory Enhancement Drugs Market Share by Type (2015-2020)
Table 77. India Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. India Memory Enhancement Drugs Market Share by Application (2015-2020)
Table 79. Central & South America Key Players Memory Enhancement Drugs Revenue (2019-2020) (Million US$)
Table 80. Central & South America Key Players Memory Enhancement Drugs Market Share (2019-2020)
Table 81. Central & South America Memory Enhancement Drugs Market Size by Type (2015-2020) (Million US$)
Table 82. Central & South America Memory Enhancement Drugs Market Share by Type (2015-2020)
Table 83. Central & South America Memory Enhancement Drugs Market Size by Application (2015-2020) (Million US$)
Table 84. Central & South America Memory Enhancement Drugs Market Share by Application (2015-2020)
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. Shire Pharmaceuticals Company Details
Table 96. Shire Pharmaceuticals Business Overview
Table 97. Shire Pharmaceuticals Product
Table 98. Shire Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$)
Table 99. Shire Pharmaceuticals Recent Development
Table 100. Allergan Plc Company Details
Table 101. Allergan Plc Business Overview
Table 102. Allergan Plc Product
Table 103. Allergan Plc Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$)
Table 104. Allergan Plc Recent Development
Table 105. Cephalon Company Details
Table 106. Cephalon Business Overview
Table 107. Cephalon Product
Table 108. Cephalon Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$)
Table 109. Cephalon Recent Development
Table 110. AlternaScript Company Details
Table 111. AlternaScript Business Overview
Table 112. AlternaScript Product
Table 113. AlternaScript Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$)
Table 114. AlternaScript Recent Development
Table 115. Takeda Pharmaceutical Company Company Details
Table 116. Takeda Pharmaceutical Company Business Overview
Table 117. Takeda Pharmaceutical Company Product
Table 118. Takeda Pharmaceutical Company Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$)
Table 119. Takeda Pharmaceutical Company Recent Development
Table 120. Eisai Business Overview
Table 121. Eisai Product
Table 122. Eisai Company Details
Table 123. Eisai Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$)
Table 124. Eisai Recent Development
Table 125. Barr Pharmaceuticals Company Details
Table 126. Barr Pharmaceuticals Business Overview
Table 127. Barr Pharmaceuticals Product
Table 128. Barr Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2015-2020) (Million US$)
Table 129. Barr Pharmaceuticals Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Memory Enhancement Drugs Market Share by Type: 2020 VS 2026
Figure 2. Aricept Features
Figure 3. Razadyne Features
Figure 4. Namenda Features
Figure 5. Exelon Features
Figure 6. Provigil Features
Figure 7. Ritalin Features
Figure 8. Adderall Features
Figure 9. Others Features
Figure 10. Global Memory Enhancement Drugs Market Share by Application: 2020 VS 2026
Figure 11. Disease Treatment Case Studies
Figure 12. Academic Performance Case Studies
Figure 13. Athletic Performance Case Studies
Figure 14. Others Case Studies
Figure 15. Memory Enhancement Drugs Report Years Considered
Figure 16. Global Memory Enhancement Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Memory Enhancement Drugs Market Share by Regions: 2020 VS 2026
Figure 18. Global Memory Enhancement Drugs Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Memory Enhancement Drugs Market Share by Players in 2019
Figure 21. Global Top Memory Enhancement Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Memory Enhancement Drugs as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Memory Enhancement Drugs Revenue in 2019
Figure 23. North America Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Memory Enhancement Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Pfizer Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020)
Figure 32. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Novartis Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020)
Figure 34. Shire Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Shire Pharmaceuticals Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020)
Figure 36. Allergan Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Allergan Plc Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020)
Figure 38. Cephalon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Cephalon Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020)
Figure 40. AlternaScript Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. AlternaScript Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020)
Figure 42. Takeda Pharmaceutical Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Takeda Pharmaceutical Company Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020)
Figure 44. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Eisai Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020)
Figure 46. Barr Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Barr Pharmaceuticals Revenue Growth Rate in Memory Enhancement Drugs Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed